Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Packaging: INERT PACKAGE FOR OVERSEA SHIPMENT
Transportation: Ocean,Land,Air,Express
Supply Ability: 5000KGS MONTHLY
Port: QINGDAO,SHANGHAI,BEIJING
Saracatinib (AZD0530) is an oral small molecule Src inhibitor developed by AstraZeneca. AZD0530 has the effect of increasing bone density and reducing pain for bone metastasis of malignant tumors.
Product LOXO-292
CAS 2152628-33-4
MF C29H31N7O3
MW 525.6
Product Categories : API Intermediates > LOXO-292 Intermediate
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.